Berkshire Biomedical Corporation
Medical Devices, 5950 Berkshire Ln, Dallas, Texas, 75225, United States, 1-10 Employees
Phone Number: +13*********
Who is BERKSHIRE BIOMEDICAL CORPORATION
Berkshire Biomedical Corporation is a privately held medical device company. Berkshire is pioneering the use of biometric technologies, combined with cloud-based and physician-enabled rem...
Read More
-
Headquarters: 5950 Berkshire Ln, Dallas, Texas, 75225, United States
-
Date Founded: 2016
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 7372
|
NAICS Code: 513210 |
Show More
Does something look wrong? Fix it. | View contact records from BERKSHIRE BIOMEDICAL CORPORATION
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Berkshire Biomedical Corporation
Answer: Berkshire Biomedical Corporation's headquarters are located at 5950 Berkshire Ln, Dallas, Texas, 75225, United States
Answer: Berkshire Biomedical Corporation's phone number is +13*********
Answer: Berkshire Biomedical Corporation's official website is https://berkbiomed.com
Answer: Berkshire Biomedical Corporation's revenue is Under $1 Million
Answer: Berkshire Biomedical Corporation's SIC: 7372
Answer: Berkshire Biomedical Corporation's NAICS: 513210
Answer: Berkshire Biomedical Corporation has 1-10 employees
Answer: Berkshire Biomedical Corporation is in Medical Devices
Answer: Berkshire Biomedical Corporation contact info: Phone number: +13********* Website: https://berkbiomed.com
Answer: Berkshire Biomedical Corporation is a privately held medical device company. Berkshire is pioneering the use of biometric technologies, combined with cloud-based and physician-enabled remote management systems, to provide precise and accurate personalized medication delivery to only the Authenticated Intended User (AIUTM). The Companys lead product under development, the Computerized Oral Prescription Administration System (COPATM), is a hand-held, automated, personalized oral liquid dispensing system designed and intended to deliver controlled and non-controlled liquid oral medications to only the Authenticated Intended User upon confirmation of dual biometric identifications (fingerprint and dentition). Upon receiving regulatory authorization, the Company intends to initially seek opportunities to leverage COPA in the delivery and remote management of oral liquid medication methadone, for Medication Use for Opioid Use Disorder treatment (MOUD) and then subsequently for the delivery of controlled medications for the treatment of pain, as they have the greatest need for the benefits of COPAs features. The COPATM System is currently under development, has NOT been reviewed by the U.S. Food and Drug Administration and is not available for commercial sale.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month